Ford Motor reports first-quarter earnings on Wednesday afternoon. Wall Street is looking for an operating profit of $1.3 billion from sales of $42.7 billion.
Ford Motor reports first-quarter earnings on Wednesday afternoon. Wall Street is looking for an operating profit of $1.3 billion from sales of $42.7 billion.
Hispanolistic/E+ via Getty Images Connect Biopharma Holdings Limited ( CNTB ) is a pre-revenue company that operates in the US and China. This article will be an introductory point to what is currently happening with Connect. I will go through the risks the company faces, its pipeline, competition, and balance sheet. At this point, I am rating Connect as a risky Buy and recommend that investors wh...
Hispanolistic/E+ via Getty Images Connect Biopharma Holdings Limited ( CNTB ) is a pre-revenue company that operates in the US and China. This article will be an introductory point to what is currently happening with Connect. I will go through the risks the company faces, its pipeline, competition, and balance sheet. At this point, I am rating Connect as a risky Buy and recommend that investors who prefer stability over risk possibly stay away from this company until Phase 2 trials are complete in mid-2026. Connect Biopharma has historically experienced a significant amount of price volatility. About 5 years ago, a few months after their IPO, the stock plummeted by around 50% in a single day. Longer term, they fell from an all-time high of $28.50 to around $0.50 . Since then, the stock has recovered to $2.68 but is far from the all-time high. The reason behind this drop was Connect refusing to reveal "top-line" Phase 2 critical clinical trial data for their flagship asset, which at that time was called CBP-201, designed to treat atopic dermatitis (eczema). 5 Year Price Chart (seekingalpha.com) Company Assets CBP-201 is still the company’s main asset; they just re-evaluated what disease the formula will primarily treat in the US (asthma and COPD instead of atopic dermatitis (eczema)) and the delivery method. Currently, CBP-201 is no longer called CBP-201. It has been renamed to rademikibart. The delivery method has also been changed from a standard subcutaneous injection to an intravenous (IV) push directly into the bloodstream. Connect currently has only one pipeline drug (rademikibart) , which they are working on. They used to have two more, Icanbelimod (CBP-307) and CBP-174, but to cut costs, they were forced to stop clinical trials for these two drugs. Icanbelimod is frozen in the pipeline; it is a pill that is designed to treat ulcerative colitis and Crohn's disease. In 2023, this drug successfully completed a Phase 2 trial; however, to resume testing, Connect i...
Rush Enterprises ( RUSHB ) declares $0.19/share quarterly dividend , in line with previous. Forward yield 1.01% Payable June 10; for shareholders of record May 12; ex-div May 12. See RUSHB Dividend Scorecard, Yield Chart, & Dividend Growth. More on Rush Rush Enterprises, Inc. (RUSHA) Q4 2025 Earnings Call Transcript Rush Enterprises appoints Pollard as COO after Wilder's departure Rush Enterprises...
Rush Enterprises ( RUSHB ) declares $0.19/share quarterly dividend , in line with previous. Forward yield 1.01% Payable June 10; for shareholders of record May 12; ex-div May 12. See RUSHB Dividend Scorecard, Yield Chart, & Dividend Growth. More on Rush Rush Enterprises, Inc. (RUSHA) Q4 2025 Earnings Call Transcript Rush Enterprises appoints Pollard as COO after Wilder's departure Rush Enterprises sees Class 8 order momentum carrying into 2026 as industry clarity returns Seeking Alpha’s Quant Rating on Rush Historical earnings data for Rush
Expressive E is making its Osmose MPE keyboard (comparatively) more affordable by ditching the synthesizer and making it a simple MIDI controller. The new Osmose CE comes in two sizes, 49 and 61 keys, for $999 and $1,199, respectively. Now, $999 is pretty expensive for a MIDI controller, but it's far less than Osmose's $1,799 starting price. It's even a pretty good deal when pitted against its clo...
Expressive E is making its Osmose MPE keyboard (comparatively) more affordable by ditching the synthesizer and making it a simple MIDI controller. The new Osmose CE comes in two sizes, 49 and 61 keys, for $999 and $1,199, respectively. Now, $999 is pretty expensive for a MIDI controller, but it's far less than Osmose's $1,799 starting price. It's even a pretty good deal when pitted against its closest competitor, the $1,399 Roli Seaboard 2 . For those unfamiliar, the Osmose is one of the most unique synths on the market. It looks like a standard piano-style keyboard, but its keys move back and forth, allowing you to coax gentle bends out of … Read the full story at The Verge.
Rolls-Royce booth at the Asian Business Aviation Conference and Exhibition. Photo: VCG Rolls-Royce Holdings Plc has significantly increased its component procurement and maintenance investments in China as the British aerospace giant navigates persistent global supply chain bottlenecks. The expansion highlights how major aviation manufacturers are increasingly leaning on China’s industrial capabil...
Rolls-Royce booth at the Asian Business Aviation Conference and Exhibition. Photo: VCG Rolls-Royce Holdings Plc has significantly increased its component procurement and maintenance investments in China as the British aerospace giant navigates persistent global supply chain bottlenecks. The expansion highlights how major aviation manufacturers are increasingly leaning on China’s industrial capabilities to ease acute parts shortages and reduce maintenance backlogs that are inflating airline costs globally.
intek1 Marlboro cigarette maker Altria ( MO ) is set to post first-quarter results on Thursday, before markets open. Wall Street expects the Richmond, Virginia-based tobacco giant to post EPS of $1.25, implying a rise of 1.6%, while revenue is expected to rise 1.3% to $4.58B during the quarter. Over the last two years, Altria has beaten both revenue and EPS estimates 63% of the time. Investors wil...
intek1 Marlboro cigarette maker Altria ( MO ) is set to post first-quarter results on Thursday, before markets open. Wall Street expects the Richmond, Virginia-based tobacco giant to post EPS of $1.25, implying a rise of 1.6%, while revenue is expected to rise 1.3% to $4.58B during the quarter. Over the last two years, Altria has beaten both revenue and EPS estimates 63% of the time. Investors will keep an eye on Altria’s shipment volume amid pricing pressure and a cautious consumer spending environment due to an uncertain economy. Altria, in January, posted fourth quarter results , where profit fell slightly short of estimates, while sales dropped 2.1%, primarily driven by lower net revenues in the smokeable products segment. Earlier this month, rival Philip Morris International ( PM ) said its Q1 revenue increased by 2.7% organically, mainly reflecting a favorable pricing variance driven by international combustibles. However, total shipment volume was down 1.9%. Seeking Alpha analysts and Seeking Alpha’s Quant ratings are cautious and rated the stock a Hold. In contrast, Wall Street considers it a Buy. “Altria is expected to maintain a slightly faster, but quite steady, earnings growth trajectory with a 2.0% Compound Annual Growth Rate in the next five years,” noted a recent Seeking Alpha analysis , adding that the growth projection is largely driven by the concern of two factors, namely, the secular decline of Altria’s traditional cigarette shipment volumes and also the uncertainties with its new products. “However, given the current valuation metrics and the growth catalysts afoot, I keep seeing plenty of runway ahead and thus maintain my strong buy rating,” the analysis added. Over the last three months, EPS estimates have seen two upward revisions , compared to four downward revisions. Revenue estimates have been revised upward four times versus two downward moves. The stock has risen nearly 18% so far this year, outperforming the over 4% rise in the broader ...
General Motors had a pretty good quarter if you don't compare it to last year, but the company is looking ahead and expects to shake up the autonomous driving industry by 2028. GM reported its first-quarter earnings results before the opening bell on Tuesday, April 28. Earnings were down, revenue ...
General Motors had a pretty good quarter if you don't compare it to last year, but the company is looking ahead and expects to shake up the autonomous driving industry by 2028. GM reported its first-quarter earnings results before the opening bell on Tuesday, April 28. Earnings were down, revenue ...
Apple lost its bid to pause court-ordered App Store payment changes, keeping external purchase links in place as its case with Epic heads toward the Supreme Court.
Apple lost its bid to pause court-ordered App Store payment changes, keeping external purchase links in place as its case with Epic heads toward the Supreme Court.
Apple lost its bid to pause court-ordered App Store payment changes, keeping external purchase links in place as its case with Epic heads toward the Supreme Court.
Apple lost its bid to pause court-ordered App Store payment changes, keeping external purchase links in place as its case with Epic heads toward the Supreme Court.
Starbucks CEO Brian Niccol says more customers are coming in every day and they saw sales growth in every income cohort during the second quarter. He speaks to Bloomberg’s Romaine Bostick.
Starbucks CEO Brian Niccol says more customers are coming in every day and they saw sales growth in every income cohort during the second quarter. He speaks to Bloomberg’s Romaine Bostick.
ridham supriyanto/iStock Editorial via Getty Images Volvo Cars on Wednesday said rising U.S. tariffs and the removal of electric vehicle subsidies weighed on its first-quarter performance, though cost-cutting measures helped limit the impact on earnings. Operating profit fell 16% to 1.6 billion Swedish crowns, while sales dropped 11% year-on-year. The company said it had underestimated the impact ...
ridham supriyanto/iStock Editorial via Getty Images Volvo Cars on Wednesday said rising U.S. tariffs and the removal of electric vehicle subsidies weighed on its first-quarter performance, though cost-cutting measures helped limit the impact on earnings. Operating profit fell 16% to 1.6 billion Swedish crowns, while sales dropped 11% year-on-year. The company said it had underestimated the impact of the U.S. decision to scrap EV tax credits, which previously supported demand for plug-in hybrid models. U.S. sales declined 32% in the quarter, with plug-in hybrid sales falling 49% and fully electric vehicle sales down 14%. CEO Hakan Samuelsson said the loss of incentives had a significant effect, as customers previously received subsidies of up to $7,500 for plug-in hybrids as well as EVs. The policy shift followed the removal of the federal EV tax credit in late September by U.S. President Donald Trump, a move automakers say risks slowing the country’s electric vehicle transition. Sales in China fell 17%, while Europe remained comparatively stable, helping offset some weakness in key export markets. Despite growing price competition from rivals offering deeper discounts, Volvo said it will maintain its premium pricing strategy to protect margins rather than pursue higher volumes. Chief Commercial Officer Erik Severinson said the company would avoid joining a broader industry trend toward aggressive discounting, even if it limits short-term sales. Volvo currently imports most of its U.S.-sold vehicles from Europe but plans to increase local production. It aims to build its XC60 hybrid in South Carolina later this year, with further plug-in hybrid production planned toward the end of the decade. The company expects continued margin pressure in the second quarter as it scales up production of its new EX60 electric SUV. However, it forecasts stronger performance in the second half of the year as new models ramp up and cost savings take full effect. The automaker is majori...
Visa 's stock price is likely to benefit as the payments processor prepares for a windfall tied to the 2026 FIFA World Cup , according to Wolfe Research. The research firm has an outperform on Visa and raised its price target on the stock Wednesday to $395 from $385, implying 28% upside from Tuesday's close. "Feedback [on Visa's earnings call] surrounded this year's marketing contribution to [valu...
Visa 's stock price is likely to benefit as the payments processor prepares for a windfall tied to the 2026 FIFA World Cup , according to Wolfe Research. The research firm has an outperform on Visa and raised its price target on the stock Wednesday to $395 from $385, implying 28% upside from Tuesday's close. "Feedback [on Visa's earnings call] surrounded this year's marketing contribution to [value-added services] growth from the … World Cup as well as [foreign exchange volume] assumption implicit in guidance," analyst Darrin Peller said in a 10-page report to clients. "Overall, commentary suggests that VAS growth was broad-based and should have a sizable runaway beyond this year, especially in the context of greater agentic-led fraud demands." Visa on Tuesday reported better-than-expected fiscal second-quarter results, and raised its forecast for the current fiscal year, partially due to the expected impact of the FIFA World Cup on consumer and commercial spending. In reaction, Visa soared 10% in the trading session following the earnings report. Visa is the official payments partner for FIFA's global soccer event, which is expected to attract more than 1.2 million visitors to the New York-New Jersey area this summer, according to FIFA. More broadly, Wolfe Research said Visa customers' spending trends "remain healthy," despite a dip in travel-related purchases due to the Iran war. That decline has been offset by stronger cross-border e-commerce spending, however, Wolfe added. The recommendation on Visa matches the consensus view on Wall Street. Of 42 analysts covering Visa, 39 rate it a buy or strong buy, LSEG data shows. Shares have fallen nearly 12% in 2026.